
Orexin receptor antagonists (ORA)
Davigo — an innovative drug with a low-dependency profile.
Newer mechanism: blocks the wakefulness signal rather than sedating the brain.
Lower dependence and rebound profile than GABA-A agents; next-day drowsiness is the main consideration.
Helps you fall and stay asleep with a different approach.

























